OPRX.NASDAQOptimizerx CORP

Form 4: OptimizeRx Director Gregory Wasson Acquires RSUs

Sentiment:

Insider Transaction Filing


OptimizeRx Corp. reports that Director Gregory D. Wasson was granted restricted stock units (RSUs) on June 9, 2026, vesting on the earlier of the first anniversary of the grant or the company's next annual meeting.

Summary

  • Director Gregory D. Wasson received a grant of 34,517 restricted stock units (RSUs) on June 9, 2026.
  • These RSUs represent a contingent right to receive shares of OptimizeRx common stock.
  • The RSUs are set to vest in full on the earlier of the first anniversary of the grant date or the date of the Company's next annual shareholder meeting.
  • Following the transaction, Wasson beneficially owns 91,700 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation grant to a director rather than a significant financial event or strategic shift.

Positives

  • Director Gregory D. Wasson has been granted a significant number of restricted stock units, indicating continued alignment with the company's performance.
  • The grant of RSUs suggests management confidence and a focus on long-term value creation for shareholders.

Future Outlook

The RSUs will vest on the earlier of the first anniversary of the grant date or the date of the Company's next annual shareholder meeting, suggesting a forward-looking incentive tied to continued service and company performance.

Industry Context

StockSavvy.ai notes that grants of restricted stock units to directors are a common practice in the technology and healthcare sectors, including companies like OptimizeRx, to align executive and director interests with long-term shareholder value.

Stakeholder Impact

  • Shareholders: The grant of RSUs to a director aligns their interests with long-term company performance, potentially benefiting shareholders if the stock price appreciates.
  • Employees: This type of compensation for directors is standard and does not directly impact employees, though it reflects the company's compensation philosophy.

Next Steps

  • Vesting of restricted stock units on the earlier of the first anniversary of the grant date or the company's next annual shareholder meeting.

Key Dates

DateDescription
06/09/2026Date of earliest transaction and grant of restricted stock units.
06/10/2026Date of filing signature.

Keywords

OptimizeRx Corp, OPRX, Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Director Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.